Market Tracker

02/12 5:16pm ET

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

120.22
Delayed Data
As of Feb 12
 +25.93 / +27.50%
Today’s Change
89.76
Today|||52-Week Range
314.88
-19.50%
Year-to-Date

Today’s Trading

Previous close94.29
Today’s open95.36
Day’s range91.50 - 128.75
Volume4,069,691
Average volume (3 months)620,426
Market cap$2.9B
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)-262.50%
Earnings growth (this year)+32.98%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+7.40%
P/E ratioNM
Price/Sales1,861.70
Price/Book11.15

Competitors

 Today’s
change
Today’s
% change
CBPOChina Biologic Produ...+0.29+0.27%
AKRXAkorn Inc+1.30+5.74%
NBIXNeurocrine Bioscienc...+0.67+1.89%
ANACAnacor Pharmaceutica...+2.38+3.47%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateMarch 14, 2016
EPS forecast (this quarter)-$3.17
Annual revenue (last year)$1.7M
Annual profit (last year)-$283.2M
Net profit margin-16,262.23%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark E. Pruzanski
Chief Financial Officer, Secretary &
Treasurer
Barbara Gayle Duncan
Corporate headquarters
New York, New York

Forecasts